Gossamer Bio Inc (GOSS)
0.8861
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 11:39
Gossamer Bio Market Cap: 200.46M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 200.51M |
| November 01, 2024 | 197.65M |
| October 31, 2024 | 198.63M |
| October 30, 2024 | 202.70M |
| October 29, 2024 | 206.84M |
| October 28, 2024 | 207.45M |
| October 25, 2024 | 212.90M |
| October 24, 2024 | 203.60M |
| October 23, 2024 | 201.12M |
| October 22, 2024 | 201.23M |
| October 21, 2024 | 208.36M |
| October 18, 2024 | 217.63M |
| October 17, 2024 | 217.74M |
| October 16, 2024 | 219.44M |
| October 15, 2024 | 218.99M |
| October 14, 2024 | 213.06M |
| October 11, 2024 | 218.31M |
| October 10, 2024 | 222.54M |
| October 09, 2024 | 228.49M |
| October 08, 2024 | 230.75M |
| October 07, 2024 | 237.54M |
| October 04, 2024 | 242.06M |
| October 03, 2024 | 228.49M |
| October 02, 2024 | 237.54M |
| October 01, 2024 | 237.54M |
| Date | Value |
|---|---|
| September 30, 2024 | 223.15M |
| September 27, 2024 | 217.18M |
| September 26, 2024 | 215.37M |
| September 25, 2024 | 222.38M |
| September 24, 2024 | 224.85M |
| September 23, 2024 | 226.23M |
| September 20, 2024 | 237.54M |
| September 19, 2024 | 217.13M |
| September 18, 2024 | 206.12M |
| September 17, 2024 | 203.31M |
| September 16, 2024 | 205.87M |
| September 13, 2024 | 208.45M |
| September 12, 2024 | 199.08M |
| September 11, 2024 | 201.36M |
| September 10, 2024 | 208.24M |
| September 09, 2024 | 210.39M |
| September 06, 2024 | 205.87M |
| September 05, 2024 | 217.34M |
| September 04, 2024 | 194.28M |
| September 03, 2024 | 196.21M |
| August 30, 2024 | 198.58M |
| August 29, 2024 | 194.76M |
| August 28, 2024 | 199.42M |
| August 27, 2024 | 206.73M |
| August 26, 2024 | 208.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
91.29M
Minimum
Mar 17 2023
1.634B
Maximum
Dec 11 2019
593.94M
Average
658.06M
Median
Mar 24 2020
Market Cap Benchmarks
| Bioxytran Inc | 7.806M |
| NovaBay Pharmaceuticals Inc | 3.762M |
| Palatin Technologies Inc | 24.04M |
| iBio Inc | 23.15M |
| Theriva Biologics Inc | 1.990M |
Market Cap Related Metrics
| Price to Book Value | 2.459 |
| Price | 0.8861 |
| Earnings Yield | -37.24% |